Access Pharmaceuticals
Access Pharmaceuticals implements one for five reverse stock split
Published in Healthcare Finance, Tax and Law Weekly, July 5th, 2006
The company's new ticker symbol is "ACCP" and the company's common stock will be traded on the OTC Bulletin Board.
The shareholders at a meeting May 19, 2006 approved a five to one reverse stock split of the company's common stock. After giving effect to the one for five reverse stock split, the company will have approximately 3.5 million shares outstanding. Shareholders will be notified by American Stock Transfer & Trust Company, Access' stock transfer agent, regarding the process for receiving new share certificates.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Accu-Break Pharmaceuticals
Accu-Break, Strides Arcolab enter joint venture to develop generic pharmaceuticals - Aceto Corporation
Aceto to make investment in India by establishing new subsidiary - Advanced Medical Optics
Advanced Medical Optics offers notes, repurchases $500M in common stock - Aeolus Pharmaceuticals
Aeolus Pharmaceuticals completes $5M financing from new institutional investors - Alnylam Pharmaceuticals
Alnylam issued U.S. patent broadly covering RNAi therapeutics - Alphatec Holdings
Alphatec Holdings prices $83.7M initial public offering - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
